0

Liver Disease Collection
 1-20 of 992 Articles
Reviews |  6 September 2016
Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysisHepatitis C Core Antigen Testing
J. Morgan Freiman, MD; Trang M. Tran, BA; Samuel G. Schumacher, MSc, PhD; et al.
Ann Intern Med. 2016;165(5):345-355. doi:10.7326/M16-0065
Original Research |  6 September 2016
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized TrialLong-Term Pioglitazone for Patients With NASH and Prediabetes or T2DM
Kenneth Cusi, MD; Beverly Orsak, RN; Fernando Bril, MD; et al.
Ann Intern Med. 2016;165(5):305-315. doi:10.7326/M15-1774
Editorials |  6 September 2016
Pioglitazone: An Addition to Our Toolbox for Patients With Diabetes and Nonalcoholic Steatohepatitis?Pioglitazone for Patients With Diabetes and Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez, MD, PhD; Leon A. Adams, MBBS, PhD
Ann Intern Med. 2016;165(5):373-374. doi:10.7326/M16-1303
Web Exclusives |  6 September 2016 FREE
Annals for Educators - 6 September 2016Annals for Educators - 6 September 2016
Darren B. Taichman, MD, PhD
Ann Intern Med. 2016;165(5):ED5. doi:10.7326/AFED201609060
Ideas and Opinions |  16 August 2016
What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States?Hepatitis B and C Could Be Rare
Gillian J. Buckley, PhD, MPH; Brian L. Strom, MD, MPH
Ann Intern Med. 2016;165(4):284-285. doi:10.7326/M16-0772
Original Research |  9 August 2016 ONLINE FIRST
Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized TrialElbasvir–Grazoprevir in Persons With HCV Receiving OAT
Gregory J. Dore, MD; Frederick Altice, MD; Alain H. Litwin, MD; et al.
Ann Intern Med. Published online 9 August 2016 doi:10.7326/M16-0816
Original Research |  7 June 2016
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort StudyOutcomes in Adults With Acute Liver Failure Between 1998 and 2013
Adrian Reuben, MBBS; Holly Tillman, MS; Robert J. Fontana, MD; et al.
Ann Intern Med. 2016;164(11):724-732. doi:10.7326/M15-2211
Original Research |  19 January 2016
Prevention of Hepatitis C by Screening and Treatment in U.S. PrisonsPrevention of Hepatitis C in U.S. Prisons
Tianhua He, MD; Kan Li, MS; Mark S. Roberts, MD, MPP; et al.
Ann Intern Med. 2016;164(2):84-92. doi:10.7326/M15-0617
Editorials |  5 January 2016
Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and ProphylaxisEvidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis
Vincent Lo Re, III, MD, MSCE; Mindy Schuster, MD, MSCE
Ann Intern Med. 2016;164(1):64-65. doi:10.7326/M15-2722
Original Research |  15 December 2015
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized TrialAnti-HCV Regimens in Noncirrhotic Patients With Genotype 1 Infection
Anita Kohli, MD; Sarah Kattakuzhy, MD; Sreetha Sidharthan, BS; et al.
Ann Intern Med. 2015;163(12):899-907. doi:10.7326/M15-0642
Original Research |  1 December 2015
Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized TrialSofosbuvir With Velpatasvir for Treatment-Naive HCV-Infected Patients
Gregory T. Everson, MD; William J. Towner, MD; Mitchell N. Davis, DO; et al.
Ann Intern Med. 2015;163(11):818-826. doi:10.7326/M15-1000
Original Research |  1 December 2015
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized TrialSofosbuvir Plus Velpatasvir for Patients With HCV Infection
Stephen Pianko, MD, PhD; Steven L. Flamm, MD; Mitchell L. Shiffman, MD; et al.
Ann Intern Med. 2015;163(11):809-817. doi:10.7326/M15-1014
Original Research |  3 November 2015
Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort StudyIncident HBV Infection in MSM
Oluwaseun Falade-Nwulia, MD, MPH; Eric C. Seaberg, PhD; Anna E. Snider; et al.
Ann Intern Med. 2015;163(9):673-680. doi:10.7326/M15-0547
Original Research |  18 August 2015
Underascertainment of Acute Hepatitis C Virus Infections in the U.S. Surveillance System: A Case Series and Chart ReviewUnderascertainment of Acute HCV Infections
Shauna Onofrey, MPH; Jasneet Aneja, MPH; Gillian A. Haney, MPH; et al.
Ann Intern Med. 2015;163(4):254-261. doi:10.7326/M14-2939
Editorials |  18 August 2015
Celebrating the ACP Centennial: From the Annals Archive—Non-A, Non-B HepatitisCelebrating the ACP Centennial
Deborah Cotton, MD, MPH
Ann Intern Med. 2015;163(4):315. doi:10.7326/M15-1300
Medicine and Public Issues |  4 August 2015 FREE
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United StatesMedicaid Restrictions of Sofosbuvir for Hepatitis C
Soumitri Barua; Robert Greenwald, JD; Jason Grebely, PhD; et al.
Ann Intern Med. 2015;163(3):215-223. doi:10.7326/M15-0406
Original Research |  7 July 2015
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized TrialC-EDGE Treatment-Naive Trial of Grazoprevir–Elbasvir
Stefan Zeuzem, MD; Reem Ghalib, MD; K. Rajender Reddy, MD; et al.
Ann Intern Med. 2015;163(1):1-13. doi:10.7326/M15-0785
Original Research |  16 June 2015
Effect of Allowing Choice of Diet on Weight Loss: A Randomized TrialEffect of Allowing Choice of Diet on Weight Loss
William S. Yancy, Jr., MD; Stephanie B. Mayer, MD; Cynthia J. Coffman, PhD; et al.
Ann Intern Med. 2015;162(12):805-814. doi:10.7326/M14-2358
Reviews |  19 May 2015 FREE
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysisImaging Techniques for Diagnosis and Staging of Hepatocellular Carcinoma
Roger Chou, MD; Carlos Cuevas, MD; Rongwei Fu, PhD; et al.
Ann Intern Med. 2015;162(10):697-711. doi:10.7326/M14-2509
Letters |  16 December 2014
Screening for and Prevalence of Hepatitis B Virus Infection Among High-Risk Veterans Under the Care of the U.S. Department of Veterans Affairs: A Case Report
Lisa I. Backus, MD, PhD; Pamela S. Belperio, PharmD; Timothy P. Loomis, PhD; et al.
Ann Intern Med. 2014;161(12):926-928. doi:10.7326/L14-5036
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)